44
Participants
Start Date
August 31, 2015
Primary Completion Date
December 31, 2017
Study Completion Date
December 31, 2017
Oral Insulin
Total of 12 months treatment; dose escalation scheme: daily treatment with 7.5 mg or placebo for 3 months; increasing to daily treatment with 22.5 mg or placebo for the following 3 months; increasing to daily treatment with 67.5 mg or placebo for the last 6 months of the treatment period.
Placebo
Total of 12 months treatment; daily treatment with insulin or placebo capsules containing filling substance (microcrystalline cellulose).
Forschergruppe Diabetes, Klinikum rechts der Isar, Technische Universität München, Lehrstuhl für Diabetes und Gestationsdiabetes der Technischen Universität München, München
Collaborators (1)
Technische Universität Dresden
OTHER
Ludwig-Maximilians - University of Munich
OTHER
Helmholtz Zentrum München
INDUSTRY
German Center for Diabetes Research
OTHER
Technical University of Munich
OTHER